NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Inari Medical, Inc. (NASDAQ: NARI)Click to Take Action Inari Medical, Inc. has entered into a definitive agreement with Stryker for $80.00 per share in cash. The transaction is expected to close in the first quarter. Quanterix Corporation (NASDAQ:QTRX)Click to Take Action Quanterix Corporation has agreed to be acquired by Akoya Biosciences, Inc. After the proposed transaction is finalized, Quanterix shareholders will hold roughly 70% ownership of the combined company. Cross Country Healthcare, Inc. (NASDAQ: CCRN)Click to Take Action Cross Country Healthcare, Inc. has entered into a definitive agreement with Aya Healthcare for $18.61 per share. Following the merger, Cross Country will go private and operate as a separate brand under Aya. Vitesse Energy, Inc. (NYSE: VTS)Click to Take Action Vitesse Energy, Inc. has entered into a merger agreement with Lucero Energy Corp. As part of the proposed transaction, Vitesse plans to issue 8,175,000 shares of common stock to Lucero shareholders. After the transaction is completed, Vitesse shareholders are anticipated to hold approximately 80% ownership of the combined company. Why Your Participation Matters: SHAREHOLDER CASES: ADDRESSING THE INJUSTICE As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™ How to Get Involved: Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at [email protected] or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts: Moon K. Young Chief of Operations Kuehn Law, PLLC 53 Hill Street, Suite 605 Southampton, NY 11968 [email protected] (833) 672-0814
Kuehn Law Encourages NARI, QTRX, CCRN, and VTS Investors to Contact Law Firm
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...